Amanta Healthcare Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Amanta Healthcare Ltd · Outcome · 03 Nov 2026, 10:46 pm
Amanta Healthcare Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 8,313 (+17.3% YoY | +20.8% QoQ) ■ EBITDA: 1,719 (+17.4% YoY | +18.3% QoQ) ■ EBITDA Margin (%): 20.7 (+2 bps YoY | -45 bps QoQ) ■ PAT: 486 (+302.6% YoY | +46.8% QoQ) ■ EPS (INR): 1.25 (+303.2% YoY | +47.1% QoQ)
Original exchange filing (PDF)
More announcements from Amanta Healthcare Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishal Ashokkumar Patel · 18 Nov 2026
- submission of Disclosures under Regulation 7(2) of The SEBI (Prohibition of Insider Trading) Regulations, 2015 - off-market transfer of equity shares · 18 Nov 2026
- Company Response On The Spurt In Volume Of Security Across Exchanges · 14 Nov 2026
- The Exchange has sought clarification from Amanta Healthcare Ltd on November 13, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. · 13 Nov 2026
- Transcript of Post Results Conference call held on November 4, 2026 · 09 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jitendrakumar Jashbhai Patel · 09 Nov 2026
- submission of Disclosure under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (the "Insider Trading Regulations") · 07 Nov 2026
- submission of Audio Recording of Post Results Conference Call held on November 4, 2026 · 04 Nov 2026
